(Q42231438)

English

Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a multicentre, double-blind, randomised controlled trial

scientific article published on 17 September 2013

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a multicentre, double-blind, randomised controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

multicenter clinical trial

0 references

cystic fibrosis

0 references

0 references

1 reference

based on heuristic

inferred from title

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24461664%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Patricia C Valery

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24461664%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24461664%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24461664%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

object named as

Abbey Diaz

8

0 references

Gabrielle Mccallum

9

0 references

object named as

Keith Grimwood

4

0 references

Paul J Torzillo

5

object named as

Paul J Torzillo

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24461664%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

I Brent Masters

7

object named as

I Brent Masters

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24461664%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

author name string

Peter S Morris

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24461664%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Paul A Bauert

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24461664%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Charmaine Mobberley

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24461664%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Irene Tjhung

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24461664%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Kim M Hare

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24461664%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

17 September 2013

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

The Lancet. Respiratory medicine

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24461664%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24461664%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24461664%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

610-620

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24461664%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Emerging drugs for bronchiectasis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Longitudinal growth and lung function in pediatric non-cystic fibrosis bronchiectasis: what influences lung function stability?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Bronchiectasis in Central Australia: a young face to an old disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Airway microbiology and host defences in paediatric non-CF bronchiectasis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Macrolide antibiotics for cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of macrolides in childhood non-cystic fibrosis-related bronchiectasis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Lung development and adult lung diseases

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Respiratory Bacterial Pathogens in the Nasopharynx and Lower Airways of Australian Indigenous Children with Bronchiectasis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Azithromycin for Indigenous children with bronchiectasis: study protocol for a multi-centre randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of airway neutrophils by sputum colour: correlation with airways inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Hospital-Based Case-Control Study of Bronchiectasis in Indigenous Children in Central Australia

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A multi-method assessment of treatment adherence for children with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of long-term low-dose azithromycin in patients with non-CF bronchiectasis.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of roxithromycin on airway responsiveness in children with bronchiectasis: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Risks of population antimicrobial resistance associated with chronic macrolide use for inflammatory airway diseases

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Mass distribution of azithromycin for trachoma control is associated with increased risk of azithromycin-resistant Streptococcus pneumoniae carriage in young children 6 months after treatment

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective study of the impact of community-based azithromycin treatment of trachoma on carriage and resistance of Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Emerging pneumococcal carriage serotypes in a high-risk population receiving universal 7-valent pneumococcal conjugate vaccine and 23-valent polysaccharide vaccine since 2001.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The clinical significance of macrolide-resistant Streptococcus pneumoniae: it's all relative

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Failure of Macrolide Antibiotic Treatment in Patients with Bacteremia Due to Erythromycin‐Resistant Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Skin disorders, including pyoderma, scabies, and tinea infections

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

High burden of staphylococcal disease in indigenous communities

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of mass treatment with azithromycin in trachoma-endemic communities with short-term reduced risk of diarrhea in young children

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Childhood mortality in a cohort treated with mass azithromycin for trachoma

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Sensorineural hearing loss as a probable serious adverse drug reaction associated with low-dose oral azithromycin.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Otitis media in young Aboriginal children from remote communities in Northern and Central Australia: a cross-sectional survey

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidemiology of nontuberculous mycobacterial infections and associated chronic macrolide use among persons with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhaled therapies, azithromycin and Mycobacterium abscessus in cystic fibrosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Indigenous health in Australia, New Zealand, and the Pacific.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnosing and preventing chronic suppurative lung disease (CSLD) and bronchiectasis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Differences and similarities in non-cystic fibrosis bronchiectasis between developing and affluent countries

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Respiratory health outcomes 1 year after admission with severe lower respiratory tract infection

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Bronchoarterial ratio and bronchial wall thickness on high-resolution CT in asymptomatic subjects: correlation with age and smoking.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-dose, volumetric helical CT: image quality, radiation dose, and usefulness for evaluation of bronchiectasis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Defining pulmonary exacerbation in children with non-cystic fibrosis bronchiectasis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessing response to treatment of exacerbations of bronchiectasis in adults.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S2213-2600(13)70185-1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24461664%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24461664%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42231438&oldid=2178749173"